CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - CytoSorbents (NASDAQ:CTSO)
PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its